BioCentury | Jan 12, 2018
Company News

Moderna advances pipeline with Phase II of AZD-8601

Moderna Therapeutics Inc. (Cambridge, Mass.) said AZD-8601 will be its first program to advance into Phase II testing. This quarter, the company plans to begin a Phase IIa trial of the candidate, which is partnered...
Items per page:
1 - 1 of 1